Treatment of patients with resistant urogenital infection
- 作者: Kul'chavenya EV1, Breusov AA1, Kulchavenya EV1, Breusov AA1
-
隶属关系:
- 期: 编号 1 (2011)
- 页面: 17-21
- 栏目: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/278998
- ID: 278998
如何引用文章
全文:
详细
In our trial 43 patients with urogenital infections resistant to standard therapy received the same basic therapy (4 tablets of safocid a day for 5 days) which, on demand, was combined with pathogenetic and symptomatic treatment. The effect was achieved by both subjective and objective parameters: pathogenic microflora was not detected after 10 days in 39 (90.7%) patients; none of the patients discharged protozoa, fungi. Tests for chlamidia were negative in all the carriers in 2 months, for ureaplasma - in 94.1% males and 83.3% females, respectively. A significant response was observed in 38 of 43 (88.4%) patients, improvement was seen in 5 (11.6%) patients. The above results persisted for 2 months of follow-up.
参考
- Пушкарь Д. Ю., Сегал А. С. Хронический абактериальный простатит: современное понимание проблемы. Врачеб. сословие 2004; 5-6: 9-11.
- Naber K. G., Bergman B., Bishop M. C. EAU Guidelines on urinary and male genital tract infections. 2002: 49-55.
- Кульчавеня Е. В., Казанцева К. П., Романовский М. А. и др. Результаты исследования СЕЗАН - по Сибири и Дальнему Востоку. Врачеб. сословие 2007; 3: 4-6.
- Кульчавеня Е. В., Казанцева К. П., Романовский М. Д. и др. Сексуальная функция сибиряков по данным анкетирования (исследование СЕЗАН). Рус. мед. журн. 2007; 15 [29 (310)]: 2241-2243.
- Куксин В. М. Дифференциальная диагностика туберкулеза предстательной железы: Автореф. дис. ... канд. мед. наук. Новосибирск; 2003.
补充文件
